BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24705496)

  • 21. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis.
    McGillicuddy FC; Harford KA; Reynolds CM; Oliver E; Claessens M; Mills KH; Roche HM
    Diabetes; 2011 Jun; 60(6):1688-98. PubMed ID: 21515850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage HIF-1α mediates obesity-related adipose tissue dysfunction via interleukin-1 receptor-associated kinase M.
    Poblete JMS; Ballinger MN; Bao S; Alghothani M; Nevado JB; Eubank TD; Christman JW; Magalang UJ
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E689-E700. PubMed ID: 32154744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppressing adipocyte inflammation promotes insulin resistance in mice.
    Zhu Q; An YA; Kim M; Zhang Z; Zhao S; Zhu Y; Asterholm IW; Kusminski CM; Scherer PE
    Mol Metab; 2020 Sep; 39():101010. PubMed ID: 32408016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of GM-CSF in adipose tissue inflammation.
    Kim DH; Sandoval D; Reed JA; Matter EK; Tolod EG; Woods SC; Seeley RJ
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1038-46. PubMed ID: 18765677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion.
    Gerst F; Wagner R; Kaiser G; Panse M; Heni M; Machann J; Bongers MN; Sartorius T; Sipos B; Fend F; Thiel C; Nadalin S; Königsrainer A; Stefan N; Fritsche A; Häring HU; Ullrich S; Siegel-Axel D
    Diabetologia; 2017 Nov; 60(11):2240-2251. PubMed ID: 28791439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of 11β-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-κB and HIF-1α.
    Lee JH; Gao Z; Ye J
    Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1035-41. PubMed ID: 23512810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice.
    Jiang C; Qu A; Matsubara T; Chanturiya T; Jou W; Gavrilova O; Shah YM; Gonzalez FJ
    Diabetes; 2011 Oct; 60(10):2484-95. PubMed ID: 21873554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quercetin attenuates adipose hypertrophy, in part through activation of adipogenesis in rats fed a high-fat diet.
    Perdicaro DJ; Rodriguez Lanzi C; Gambarte Tudela J; Miatello RM; Oteiza PI; Vazquez Prieto MA
    J Nutr Biochem; 2020 May; 79():108352. PubMed ID: 32145471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adipocyte PU.1 knockout promotes insulin sensitivity in HFD-fed obese mice.
    Lackey DE; Reis FCG; Isaac R; Zapata RC; El Ouarrat D; Lee YS; Bandyopadhyay G; Ofrecio JM; Oh DY; Osborn O
    Sci Rep; 2019 Oct; 9(1):14779. PubMed ID: 31611602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of hyperoxia exposure on metabolic markers and gene expression in 3T3-L1 adipocytes.
    Quintero P; González-Muniesa P; García-Díaz DF; Martínez JA
    J Physiol Biochem; 2012 Dec; 68(4):663-9. PubMed ID: 22535284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of hypoxia-inducible factor-2 in adipocytes results in pathological cardiac hypertrophy.
    Lin Q; Huang Y; Booth CJ; Haase VH; Johnson RS; Celeste Simon M; Giordano FJ; Yun Z
    J Am Heart Assoc; 2013 Dec; 2(6):e000548. PubMed ID: 24326162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
    Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of varying degrees of intermittent hypoxia on proinflammatory cytokines and adipokines in rats and 3T3-L1 adipocytes.
    He Q; Yang QC; Zhou Q; Zhu H; Niu WY; Feng J; Wang Y; Cao J; Chen BY
    PLoS One; 2014; 9(1):e86326. PubMed ID: 24466027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipocyte-Macrophage Cross-Talk in Obesity.
    Engin AB
    Adv Exp Med Biol; 2017; 960():327-343. PubMed ID: 28585206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial.
    Gögebakan Ö; Osterhoff MA; Schüler R; Pivovarova O; Kruse M; Seltmann AC; Mosig AS; Rudovich N; Nauck M; Pfeiffer AF
    Diabetologia; 2015 Aug; 58(8):1759-68. PubMed ID: 25994074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Licochalcone F alleviates glucose tolerance and chronic inflammation in diet-induced obese mice through Akt and p38 MAPK.
    Bak EJ; Choi KC; Jang S; Woo GH; Yoon HG; Na Y; Yoo YJ; Lee Y; Jeong Y; Cha JH
    Clin Nutr; 2016 Apr; 35(2):414-421. PubMed ID: 25823386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beraprost sodium, a stable prostacyclin analogue, improves insulin resistance in high-fat diet-induced obese mice.
    Inoue E; Ichiki T; Takeda K; Matsuura H; Hashimoto T; Ikeda J; Kamiharaguchi A; Sunagawa K
    J Endocrinol; 2012 Jun; 213(3):285-91. PubMed ID: 22460613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte-specific HIF-1α ablation improves obesity-induced glucose intolerance by reducing first-pass GLP-1 degradation.
    Lee YS; Riopel M; Cabrales P; Bandyopadhyay GK
    Sci Adv; 2019 Jul; 5(7):eaaw4176. PubMed ID: 31281892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mangiferin ameliorates insulin resistance by inhibiting inflammation and regulatiing adipokine expression in adipocytes under hypoxic condition.
    Yang CQ; Xu JH; Yan DD; Liu BL; Liu K; Huang F
    Chin J Nat Med; 2017 Sep; 15(9):664-673. PubMed ID: 28991527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor.
    Douros JD; Lewis AG; Smith EP; Niu J; Capozzi M; Wittmann A; Campbell J; Tong J; Wagner C; Mahbod P; Seeley R; D'Alessio DA
    Diabetes; 2018 Aug; 67(8):1504-1511. PubMed ID: 29759973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.